Rashi Peripherals Share Price » National Chronicle

GPT Healthcare IPO Subscription Status: GPT Healthcare Limited on Thursday officially launched its Initial Public Offering (IPO) in the Indian market. This IPO will be available for purchase till Monday i.e. 26th February.

The company has fixed the price band of Rs 177 to Rs 186 for its equity shares. Also, GPT Healthcare is preparing for listing on both Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

GPT Healthcare IPO Subscription Status: Even before the IPO was launched in the market, GPT Healthcare has raised funding of Rs 157.54 crore from anchor investors.

Here, as of 10:18 am on the first day of bidding, the book build issue was subscribed 0.03 times, the retail portion was subscribed 0.05 times and the NII was subscribed 0.02 times.

GPT Healthcare IPO Subscription Status and Key Details

GMP (Grey Market Premium): According to market experts, shares of GPT Healthcare are trading in the gray market without any significant premium or discount.

Price Band: The multi-specialty hospital has set the issue price band at Rs 177 to Rs 186 per equity share.

How to cancel Paytm Fastag: Know each and everything

IPO Date: The IPO, which started today i.e. February 22, will remain open for subscription till February 26, 2024.

IPO size: GPT Healthcare aims to raise Rs 525.14 crore through its IPO, of which Rs 40 crore is expected to come from issuance of new shares and Rs 485.14 crore has been kept reserved for offer for sale (OFS).

Lot Size: The lot size for this IPO will be 80 shares.

Allotment Date: For now the allotment date is fixed for Tuesday, 27th February.

Registrar: Link Intime India Private Limited.

Listing: Proposed for listing on both BSE and NSE.

Listing Date: Following the T+3 listing rule, the IPO is expected to hit the secondary market on February 29, 2024.

GPT Healthcare IPO Subscription Status: Buy or Not

GPT Healthcare IPO Subscription Status: If believe on experts, this is a favorable opportunity to invest in a leading healthcare provider in eastern India. The company’s strategic focus, established presence and diverse healthcare services position it as a one-stop destination for patients’ needs. Operating in densely populated cities, GPT Healthcare exhibits healthy growth potential, catering to diverse economic sectors and increasing market penetration.

GPT Healthcare IPO Subscription Status: Investors are requested that the above article is given for information only. Use your discretion before applying for an IPO.

Paytm share price today: The shares of payment platform Paytm are continuing to fall, due to which investors are starting to worry. On Wednesday, the company’s shares witnessed a severe lower circuit of 10 per cent, setting a new all-time low of Rs 344.1.

Paytm share price today

However, there was a slight recovery later and by around 10:11 AM, Paytm shares were trading at Rs 343.6, showing a decline of 9.6 per cent. This huge decline of around 55 per cent is mainly due to the regulatory constraints imposed by the Reserve Bank of India (RBI) on the company’s subsidiary Paytm Payments Bank.

Paytm share price today: In response to the crisis in Paytm’s stock price, RBI Governor Shaktikanta Das said that this decision is final regarding regulatory action against the company and there will be no further review on it. Das said that RBI takes any action only after proper investigation.

Read also: Yes Bank Share Price on Feb 20; After two days of decline stock show some positive move

Paytm shares had reached a peak of Rs 998.3 in October last year, but within just three months the stock saw a huge fall of 65.5 percent. Comparatively speaking, the stock saw a huge decline of 85 percent from its issue price of Rs 2,150.

Paytm share price today: Recently, global brokerage company Macquarie has given ‘underperform’ rating to Paytm with a target price of Rs 275, which is a matter of concern for the company.

Macquarie’s downgrade is based on three important factors:

Paytm is at risk of losing a large number of customers following the RBI action, posing a serious threat to its monetization and business model.
The brokerage firm has revised its loss estimates for FY25E and FY26E by 170 per cent and 40 per cent respectively, taking into account the sharp decline in revenues due to lower payment and distribution revenues.
Macquarie has assumed a 50 per cent cash burn rate and applied a 20x P/E multiple to normalize earnings from Paytm’s delivery business.

Paytm share price today: In view of all this, experts advise to exercise caution and not to invest in Paytm shares and avoid speculative activities in the market. The future of the company remains uncertain.